Australia markets open in 9 hours 11 minutes

Akoya Biosciences, Inc. (AKYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.8150+0.0050 (+0.13%)
As of 10:45AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.8100
Open3.9400
Bid3.7800 x 300
Ask3.8600 x 300
Day's range3.7500 - 3.8500
52-week range3.0400 - 8.8000
Volume17,361
Avg. volume183,461
Market cap188.385M
Beta (5Y monthly)1.48
PE ratio (TTM)N/A
EPS (TTM)-1.4300
Earnings date13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.83
  • GlobeNewswire

    Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

    MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2024 after the market close on May 13th, 2024. Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance

  • GlobeNewswire

    Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

    MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial Biology 2.0 Solutions that enable unprecedented speed and scale for spatial biology studies at the American Association for Cancer Research (AACR) 2024 Annual Meeting in San Diego, April 5 to 10. In addition, the company will showcase new applications of its PhenoCode™ Signature Panels and preliminary da

  • Insider Monkey

    Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript

    Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript March 4, 2024 Akoya Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.27. AKYA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]